Profile
NOVARTIS GENE THERAPIES
🔥 High spending power🏢 Large enterprise
Last updated: 27 Aug 2024 |
Saved
ExportedNovartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal m...See more
Industry & specialities
Details
Headquarter United Kingdom of Great Britain and Northern Ireland |
Countries of operation Australia, Malaysia, Singapore, ... See more |
Year founded 1986 (38 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
Contact
Address:
hidden.address
Phone number:
hidden.number
Company email:
Website:
hidden.website
Key People
hidden.name
Value and Access Manager (Rare Diseases)
hidden.name
Senior Product Manager (Cell & Gene Therapy)
hidden.name
Medical Director (Group Countries)
View all 6 people
*This profile is created/compiled by The Grid to the best of our research ability, it is not currently maintained by or endorsed by .
Insight
Signals
The Grid’s assessment- High spending power
At a glance- Operates in multiple countries
The company has a sophisticated ownership structure and may be part of a large corporate group
The company's annual budgeting is likely to take place between October - December
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
People
NOVARTIS GENE THERAPIES has a total of 6 people across Singapore , Australia , Malaysia , and 1 other countries.
People Location
- 3· Singapore
- 1· Australia
- 1· Malaysia
- 1· Thailand
Job function
- 1Hidden function
- 1Hidden function
Seniority
- 4Hidden seniority
- 4Hidden seniority
- 2Hidden seniority
- 1Hidden seniority
Filter by:
Personnel Name
Job Function
Seniority
Job Title
People Location
Email Validity
Add filters6 people
Add to Shortlist
Export Leads
Job title | Name | Email | Country based in | Job Function | Seniority | |
|---|---|---|---|---|---|---|
Value and Access Manager (Rare Diseases) | - | hidden.item | hidden.item | hidden.item | ||
Senior Product Manager (Cell & Gene Therapy) | - | hidden.item | hidden.item | hidden.item | ||
Medical Director (Group Countries) | - | hidden.item | hidden.item | hidden.item |
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Financials
Fiscal/Budgeting Period: | October - December |
Auditor: | KPMG LLP |
Corporate-only access Contact us for a free demo now! | |
Sign up to view for free | |
View more
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Legal entities (2)
Company | Incorporation date | Country of Registration | Share capital | Local SIC  |
|---|---|---|---|---|
| 1 Aug 1986 | Singapore | SGD 100,000 | 21022: MANUFACTURE OF OTHER BIOLOGICAL PRODUCTS AND PREPARATIONS FOR HUMAN USE |
| 4 May 2007 | Singapore | SGD 1,000,000 | 46900: WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT |
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
List featured in
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has NOVARTIS GENE THERAPIES been operating for?
- What is the funding status of NOVARTIS GENE THERAPIES?
- What is the address of NOVARTIS GENE THERAPIES?
- Where is NOVARTIS GENE THERAPIES's headquarter?
- What is NOVARTIS GENE THERAPIES's contact number?
- Which countries does NOVARTIS GENE THERAPIES operate in?
- What NOVARTIS GENE THERAPIES's spending power?
- Does NOVARTIS GENE THERAPIES have a presence in the domain it operates in?
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0.
Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.